Dear Sir, With interest we read that Bottini et al. [1] claim that the epinephrine response following exercise is blunted in diabetic patients with autonomic neuropathy featuring postural hypotension (DAN § This might well be true; however, the workloadma x (% of predicted), the VO2max (% of predicted), and the maximal heart rate during exercise were lower in this group of patients (DAN+PH +) than in other groups. Hence, it is difficult to exclude a lower degree of sympathetic stimulation during exercise in DAN+PH + patients than in other subjects. Neverthe- Response from the author Dear Sir, Drs. Bergstr6m and co-workers are to be thanked for their letter and it is with great pleasure that I am going to reply to their interesting observations. All the subjects in our study underwent a sub-maximal incremental exercise test, but four out of five diabetic patients with autonomic neuropathy featuring postural hypotension (DAN+PH § stopped the effort prematurely because of physical exhaustion. Hence, the DAN+PH+group reached a lower peak VO 2 in respect to the other diabetic sub-groups, but maintained the same VO2/work relationship throughout the exercise (Fig. 4) . Therefore, it should not be a surprise that the DAN+PH + group reached a lower heart rate and lower epinephrine and norepinephrine levels. In fact, what we stressed is that the progressive exertional increase of heart rate and Corresponding author: Dr. R Bottini, Dipartimento di Medicina Interna e Scienze Endocrine e Metaboliche, Universitfi di Perugia, via Enrico Dal Pozzo, 3-06126 Perugia, Italy both norepinephrine and epinephrine, which is not influenced by the workload and the VO2 uptake reached at the end of the effort, was markedly reduced in the DAN+PH + group, suggesting a blunted sympathetic activation in this group during the exercise.
During a "steady-state" exercise test at a workload corresponding to 50 and 80 % of the respective maximal, Bergstr6m and co-workers have found lower levels of epinephrine and norepinephrine in a sub-group of diabetic patients (i. e. with an abnormal acceleration index) as compared with healthy control subjects. However, they failed to show any significant difference among the other diabetic sub-groups, either for epinephrine or for norepinephrine. It is difficult to compare our results with those of Bergstr6m and co-workers because of the different methods used to characterize the diabetic sub-groups and the different exercise testing protocol. Although we did not measure plasma levels of catecholamines in our control subjects it is worthwhile emphasising that we were the first to show a significant low increment of epinephrine and norepinephrine in the DAN+PH + group, as compared with the other diabetic sub-groups, during exercise.
Yours sincerely, R Bottini
